Andra AP fonden Makes New $361,000 Investment in Humana Inc. $HUM

Andra AP fonden purchased a new stake in shares of Humana Inc. (NYSE:HUM) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 2,082 shares of the insurance provider’s stock, valued at approximately $361,000.

A number of other large investors also recently bought and sold shares of the stock. Cassaday & Co Wealth Management LLC acquired a new position in Humana during the first quarter worth $48,000. Commerzbank Aktiengesellschaft FI acquired a new stake in shares of Humana in the first quarter valued at about $455,000. SEB Asset Management AB purchased a new stake in shares of Humana during the first quarter worth about $4,201,000. Swiss National Bank increased its stake in shares of Humana by 7.1% during the first quarter. Swiss National Bank now owns 352,960 shares of the insurance provider’s stock worth $61,200,000 after purchasing an additional 23,440 shares in the last quarter. Finally, Watershed Asset Management L.L.C. acquired a new position in shares of Humana during the 1st quarter worth about $474,000. 92.38% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on HUM shares. Wolfe Research upgraded Humana from a “hold” rating to a “strong-buy” rating in a research report on Thursday, June 4th. Robert W. Baird reduced their price objective on Humana from $264.00 to $205.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. The Goldman Sachs Group raised their price objective on Humana from $158.00 to $195.00 and gave the company a “sell” rating in a report on Thursday, April 30th. Evercore lifted their target price on shares of Humana from $250.00 to $370.00 in a research note on Thursday, June 11th. Finally, Seaport Research Partners lowered shares of Humana to a “neutral” rating in a report on Wednesday, May 20th. Two analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating, fifteen have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $327.17.

Humana Stock Down 0.8%

Shares of HUM opened at $394.37 on Friday. The company’s 50-day moving average price is $362.43 and its 200 day moving average price is $264.14. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $428.88. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66. The firm has a market cap of $47.35 billion, a P/E ratio of 42.18, a price-to-earnings-growth ratio of 2.16 and a beta of 0.71.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The firm had revenue of $39.65 billion during the quarter, compared to analysts’ expectations of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business’s quarterly revenue was up 23.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. On average, sell-side analysts forecast that Humana Inc. will post 9.46 earnings per share for the current year.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.